Many pharmaceutical and medical device companies have made commitments to address health inequities as they exist in the realm of clinical trials. Precision’s Alice Pressman co-authors this article discussing some of the obstacles, solutions, and implications for widespread efforts to improve health equity throughout the clinical research cycle.

Read Now!